Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030(RootsAnalysis)

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings

The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s).
 Elaborate profiles of key players (established after 2005) that are engaged in the development of microbiome therapeutics.
 A detailed review of the current market landscape of microbiome diagnostic tests, brief profiles of popular diagnostic developers and indicative list of screening and profiling test kits.
 A detailed assessment of the current market landscape of FMT therapies, a geographical clinical trial analysis and information on various stool banks.
 A detailed business portfolio analysis based on an attractiveness and competitiveness (AC) framework.
 An analysis of the varied microbiome-focused initiatives of big pharma players.
 An analysis of the start-ups / small-sized players engaged in the development of microbiome therapeutics and diagnostics.
 An assessment of the most commonly targeted therapeutic indications and details of microbiome-based drugs.
 An analysis of the investments made at various stages of development in start-ups / small-sized companies.
 An indicative list of contract manufacturers, in-house manufacturers and CROs that currently claim to have the necessary capabilities.
 An assessment of the emerging role of big data highlighting efforts focused on the development and implementation of various algorithms / tools to analyze data generated from in the microbiome research.

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030{RootsAnalysis}

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings.

To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html

Key Market Insights
 Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease indications; the US has emerged as the major hub for microbiome-based research
 The pipeline features both prebiotic and probiotic drugs, being evaluated across different stages of development; majority of these products are designed for administration via non-invasive routes, such as oral and topical
 Microbiome therapeutics have demonstrated the potential to target a range of therapeutic areas; digestive and GI disorders, oncology, infectious diseases, and metabolic disorders are amongst the prime focus areas
 Over 10 microbiome-focused disease diagnosis tests are already available in the market; several companies claim to have initiatives in this domain based on different sample types and therapeutic areas
 Presently, FMTs are the only commercially available microbiome products for the treatment of recurrent CDIs; in fact, several trials evaluating FMTs, sponsored by non-industry players, have been registered in the past decade
 Over time, well funded start-ups have initiated product development programs, having invested significant time and effort to explore the applicability of microbiome therapeutics across various indications

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Leave a Reply

Your email address will not be published. Required fields are marked *